Where I'll Be This Month 1:02
Positive Clinical Trial Results Posted for Masitinib 4:18
Novartis Applies for FDA & EMA Approval for Ofatumumab 6:07
High Dosage of Vitamin D Worsens MS Disability in Mice 7:15
Insurer Saves Money by Flying People to Mexico for Their Prescription Medications 10:15
My Interview with Dr. Jackie Bhattarai 13:58
Share This Episode 25:57
Reminder…Please Donate to Walk MS 26:19
___________
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/131
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jon@realtalkms.com
Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Positive Top-Line Phase 2B/3 Results for Masitinib in Progressive Forms of MS
High Dose Vitamin D Worsens Experimental CNS Autoimmune Disease By Raising T Cell-Excitatory Calcium
Jon's WALK MS Fundraising Page
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 131
Hosted By: Jon Strum
Guests: Dr. Jackie Bhattarai
Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, MSPPC20, RealTalkMS